Skip to main content
. 2019 Jan 10;8(2):492–500. doi: 10.1002/cam4.1891

Table 4.

Relationship between plasma CD4 + and CD3+ distribution and anti‐HER2 benefit

CD3+ CD4+
Upper Lower Z P Upper Lower Z P
PFS(m) 9 12 −1.639 0.101 8 12 −1.693 0.091
OS(m) 20 23 −0.797 0.327 15 24.5 −1.950 0.051

PFS: progression‐free survival; OS: overall survival. PFS and OS are displayed with the median of survival time. Mann‐Whitney U test was conducted to detect differences in survival time between the two subgroups.